MedTrace Logo

The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics

NCT05710055 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-11-24

No results posted yet for this study

Summary

The goal of this interventional study is to evaluate the efficacy of probiotics with prebiotics on overweight.

200 eligible participants with overweight will be enrolled and randomized to consume four study products for 3 months.

Reseachers will compare the four groups to evaluate whether there is significant improvement on overweight for participants in the study product of probiotics with prebiotics.

Conditions

Interventions

DIETARY_SUPPLEMENT

Study product A (Wonderlab wonder4shape)

Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months

DIETARY_SUPPLEMENT

Study product B (Wonderlab wonder4shape)

Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months

DIETARY_SUPPLEMENT

Study product C (Wonderlab wonder4shape)

Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months

DIETARY_SUPPLEMENT

Study product D

Partipants in this arm need to consume one bottle (2g) of this product once a day for 3 months

Sponsors & Collaborators

  • Shenzhen Precision Health Food Technology Co. Ltd.,

    lead OTHER_GOV

Principal Investigators

  • Weixing Wang, MD · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-06
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710055 on ClinicalTrials.gov